Cost minimization and budget impact model for introducing the fully liquid combined acellular hexavalent vaccine into the Dominican Republic’s expanded immunization plan

Key Points

• The aim is to evaluate the economic implications of introducing a hexavalent vaccine into the Dominican Republic's immunization plan.
• Cost minimization analysis performed
• Budget impact model utilized
• Comparison of adverse events and logistics costs
• Increased spending due to vaccine introduction
• Reduction in adverse events associated with vaccination
• Lower logistics costs and productivity losses observed